Trademark Overview
On Thursday, February 15, 2024, a trademark application was filed for NX with the United States Patent and Trademark Office. The USPTO has given the NX trademark a serial number of 79393467. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, October 4, 2024. This trademark is owned by Andrea Jacobs. The NX trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Recorded computer programs for use in cancer diagnosis; downloadable computer programs for use in cancer diagnosis; recorded computer programs for use in oncology; downloadable computer programs for use in oncology; downloadable software applications for medical and scientific research in the field of cancer treatment and diagnosis; downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software for the digital representation of tumors and tumor features; software for high-resolution digital image representation of the molecular composition of cellular anomalies; software for high-resolution digital image representation of a digital tumor; downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for...
Reactants for medical diagnosis; preparations for medical diagnosis; diagnostic reagents for medical or veterinary use in in vitro diagnosis; reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics reagents for diagnostic tests for medical use; diagnostic test reagents for veterinary use; diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic substances for medical use; pharmaceutical products, medical and veterinary preparations; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations; pharmaceutical preparations for the diagnosis of diseases; pharmaceutical preparations for diagnosis; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations for individual medical diagnosis pharmaceutical preparations for medical test kits; pharmaceutical preparations for medical test kits for use...
Diagnostic biomarkers for analytical, research and scientific use; diagnostic biomarkers for in vitro testing for scientific use; diagnostic biomarkers for use in assessment of genomic analysis for scientific use; diagnostic biomarkers for use in assessment of individual diagnoses of cancer; diagnostic preparations for science or research; diagnostic reagents for science or research diagnostic reagents for the diagnosis of diseases; chemicals for the production of medical diagnostic reagents, particularly for cancer research
Pharmaceutical and diagnostical consulting, particularly in the field of oncology; pharmaceutical and diagnostical consulting for businesses in the medical field; pharmaceutical and consulting for cancer treatment; disease diagnosis services; cancer diagnosis services, particularly for enabling personalized and individual medical care; disease diagnosis services, particularly in the field of oncology; disease diagnosis services in the field of proteomics; medical analysis services for cancer diagnosis and prognosis; remote monitoring of medical data for medical diagnosis; medical analysis for the diagnosis and treatment of persons; remote monitoring of medical data for medical diagnosis and treatment; medical testing services relating to the diagnosis and treatment of disease; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical diagnosis and treatment of cancer; medical diagnostic services (testing and analysis); medical diagnostic servi...
Apparatus for tumour diagnosis; medical apparatus for machine learning-based spectrum analysis of human blood plasma; scanners for medical diagnosis; apparatus for clinical diagnosis, spectrum analyzers for use in medical diagnosis; trace material analyzers for medical use in diagnosis; apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins; diagnostic oncology apparatus for medical use; diagnostic, examination, and monitoring equipment; medical tests kits for the use in oncology; medical test kits for cancer diagnosis; medical test kits for individual medical diagnosis
Cancer research; cancer diagnosis research; research in the field of proteomics; oncological research; research in the field of oncological diagnostics; technical data analysis services; development of personalized diagnostics products for cancer treatment; software-as-a-service [SaaS] for use in cancer diagnosis; platform-as-a-service [PaaS] for use in cancer diagnosis; software-as-a-service [SaaS] for use in oncology; platform-as-a-service [PaaS] for use in oncology; software-as-a-service [SaaS] for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service [PaaS] for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service [SaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; platform-as-a-service [PaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatme...
